These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21984370)

  • 1. New insight into praziquantel against various developmental stages of schistosomes.
    Wu W; Wang W; Huang YX
    Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study progress on the mode of action of praziquantel against schistosomes].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosomiasis control: keep taking the tablets.
    Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
    Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
    Xiao SH; Sun J; Chen MG
    Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility or resistance of praziquantel in human schistosomiasis: a review.
    Wang W; Wang L; Liang YS
    Parasitol Res; 2012 Nov; 111(5):1871-7. PubMed ID: 23052781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Praziquantel.
    Cioli D; Pica-Mattoccia L
    Parasitol Res; 2003 Jun; 90 Supp 1():S3-9. PubMed ID: 12811543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Ca2+ channels targets of praziquantel action?
    Greenberg RM
    Int J Parasitol; 2005 Jan; 35(1):1-9. PubMed ID: 15619510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for the control of parasitic diseases: current status and development in schistosomiasis.
    Fenwick A; Savioli L; Engels D; Robert Bergquist N; Todd MH
    Trends Parasitol; 2003 Nov; 19(11):509-15. PubMed ID: 14580962
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential of artemether for the control of schistosomiasis.
    Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
    Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 13. New approaches for understanding mechanisms of drug resistance in schistosomes.
    Greenberg RM
    Parasitology; 2013 Oct; 140(12):1534-46. PubMed ID: 23552512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosomiasis--a century searching for chemotherapeutic drugs.
    Ribeiro-dos-Santos G; Verjovski-Almeida S; Leite LC
    Parasitol Res; 2006 Oct; 99(5):505-21. PubMed ID: 16636847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in research on antischistosomal drugs].
    Qiu SJ; Xia CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosomiasis: challenges for control, treatment and drug resistance.
    Fenwick A; Webster JP
    Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosomiasis and pregnancy.
    Friedman JF; Mital P; Kanzaria HK; Olds GR; Kurtis JD
    Trends Parasitol; 2007 Apr; 23(4):159-64. PubMed ID: 17336160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
    Wang Y; Xu J; Xia C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-positioning protein-kinase inhibitors against schistosomiasis.
    Gelmedin V; Dissous C; Grevelding CG
    Future Med Chem; 2015; 7(6):737-52. PubMed ID: 25996067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosomiasis chemotherapy.
    Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
    Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.